Obesity and risk of bladder cancer: A meta-analysis of cohort studies

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 3117-3121

  Qin, Qi ^a   Xu, Xin ^b   Wang, Xiao ^b   Zheng, Xiang Yi ^b  

^a Children's Hospital   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Analysis; Bladder cancer; Confounding factor; Meta; Obesity; Risk; Smoking

Indexed keywords

ARTICLE; BLADDER TUMOR; COHORT ANALYSIS; HUMAN; META ANALYSIS; OBESITY; PROGNOSIS; RISK FACTOR;

COHORT STUDIES; HUMANS; OBESITY; PROGNOSIS; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84880341723     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.3117     Document Type: Article

References (21)

1. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
2. Chen HS, Su LT, Lin SZ, et al (2012). Increased risk of urinary tract calculi among patients with diabetes mellitus--a population-based cohort study. Urology, 79, 86-92.
3. Chow WH, Lindblad P, Gridley G, et al (1997). Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst, 89, 1453-7.
4. DerSimonian R, Laird N(1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
5. Dunn SE, Kari FW, French J, et al (1997). Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res, 57, 4667-72.
6. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
7. Flegal KM, Graubard BI, Williamson DF, Gail MH (2005). Excess deaths associated with underweight, overweight, and obesity. JAMA, 293, 1861-7.
8. Funfstuck R, Nicolle LE, Hanefeld M, Naber KG (2012). Urinary tract infection in patients with diabetes mellitus. Clin Nephrol, 77, 40-8.
9. Haggstrom C, Stocks T, Rapp K, et al (2011). Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me- Can). Int J Cancer, 128, 1890-8.
10. Jankovic S, Radosavljevic V (2007). Risk factors for bladder cancer. Tumori, 93, 4-12.
11. Jee SH, Yun JE, Park EJ, et al (2008). Body mass index and cancer risk in Korean men and women. Int J Cancer, 123, 1892-6.
12. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
13. Jones ME, Swerdlow AJ (1998). Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths. Am J Epidemiol, 148, 1012-7.
14. Key TJ, Appleby PN, Reeves GK, Roddam AW(2010). Insulinlike growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol, 11, 530-42.
15. Koebnick C, Michaud D, Moore SC, et al (2008). Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev, 17, 1214-21.
16. Larsson SC, Andersson SO, Johansson JE, Wolk A (2008). Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer, 44, 2655-60.
17. Mantel N, Haenszel W(1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
18. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al (2007). Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol, 25, 285-95.
19. Rinaldi S, Cleveland R, Norat T, et al (2010). Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer, 126, 1702-15.
20. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
21. Zhao H, Grossman HB, Spitz MR, et al (2003). Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol, 169, 714-7.